These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7539354)

  • 1. Establishment of a leukemic lymphocyte culture from human aqueous humor.
    Wang N; Yang H; Schuman JS
    Curr Eye Res; 1995 Feb; 14(2):137-43. PubMed ID: 7539354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemic glaucoma: the effects on outflow facility of chronic lymphocytic leukemia lymphocytes.
    Schuman JS; Wang N; Eisenberg DL
    Exp Eye Res; 1995 Nov; 61(5):609-17. PubMed ID: 8654503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal B cell compartment in chronic lymphatic leukemia.
    Pluta A; Górski A; Nowaczyk M; Modlińska M
    Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
    Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
    Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity.
    Witzig TE; Borell TJ; Herath JF; Tefferi A; Li CY; Jenkins RB
    Leuk Lymphoma; 1994 Aug; 14(5-6):447-51. PubMed ID: 7529078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers].
    Pluta A; Górski A; Nowaczyk M
    Pol Arch Med Wewn; 1991 Sep; 86(3):154-8. PubMed ID: 1725559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.
    Buschle M; Campana D; Carding SR; Richard C; Hoffbrand AV; Brenner MK
    J Exp Med; 1993 Jan; 177(1):213-8. PubMed ID: 7678114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
    Isaković K; Lenert G
    Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of immunophenotyping of blood and cerebrospinal fluid lymphocytes for the diagnosis of leukemic meningosis in a patient with chronic lymphatic leukemia of the B-cell type].
    Ottinger H; Petrasch S; Püllen R; Brittinger G
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():141-3. PubMed ID: 1692953
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of leukemic cell proliferation by factor(s) released from irradiated lymphocytes of B-chronic lymphocytic leukemia patients.
    Bessler H; Notti I; Cohen AM; Klein B; Djaldetti M
    Am J Hematol; 1994 Jun; 46(2):65-71. PubMed ID: 8172197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional differences of T cells in B-chronic lymphocytic leukemia.
    Antica M; Kusić B; Spaventi R; Jaksić B; Vitale B
    Leuk Lymphoma; 1993 Jan; 9(1-2):133-40. PubMed ID: 8477193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
    Cordone I; Matutes E; Catovsky D
    Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
    Pluta A
    Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
    Lotz M; Ranheim E; Kipps TJ
    J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.